REG - IXICO plc - Director/PDMR Shareholding
RNS Number : 8891ZIXICO plc15 January 202015 January 2020
IXICO plc
("IXICO" or the "Company")
Exercise of Options and PDMR Dealings
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 January 2020 that John Hall, SVP Corporate Development and PDMR, exercised 75,000 options with an exercise price of 34p.
The Company has also received notification on 10 January 2020 that Robin Wolz, SVP Research & Development and PDMR, exercised 83,882 options of which 45,176 were exercisable at 30.5p and 38,706 were exercisable at 34p. The 83,882 shares were sold to a third party at an average price of 87.6p.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
John James Hall
2
Reason for the notification
a)
Position/status
PDMR (SVP Corporate Development)
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
IXICO plc
b)
LEI
2138005M1F59O6HWSA97
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares in IXICO plc
Identification code
GB00BCLY7L40
b)
Nature of the transaction
Exercise of options
c)
Price(s) and volume(s)
Exercise Price(s)
Volume(s)
34p
75,000
d)
Aggregated information
- Aggregated volume
75,000 shares
- Price
34p
e)
Date of the transaction
10/1/20
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Robin Wolz
2
Reason for the notification
a)
Position/status
PDMR (SVP Research & Development)
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
IXICO plc
b)
LEI
2138005M1F59O6HWSA97
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares in IXICO plc
Identification code
GB00BCLY7L40
b)
Nature of the transaction
Exercise of options
c)
Price(s) and volume(s)
Exercise Price(s)
Volume(s)
30.5p
45,176
34p
38,706
d)
Aggregated information
- Aggregated volume
83,882 shares
- Price
32.1p
e)
Date of the transaction
10/1/20
f)
Place of the transaction
N/A
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Robin Wolz
2
Reason for the notification
a)
Position/status
PDMR (SVP Research & Development)
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
IXICO plc
b)
LEI
2138005M1F59O6HWSA97
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares in IXICO plc
Identification code
GB00BCLY7L40
b)
Nature of the transaction
Sale
c)
Price(s) and volume(s)
Price(s) Date
Volume(s)
92p 10/1/20
18,395
90p 13/1/20
18,395
85p 13/1/20
47,092
d)
Aggregated information
- Aggregated volume
83,882 shares
- Price
87.6p
e)
Date of the transaction
10/1/20 and 13/1/20
f)
Place of the transaction
London Stock Exchange
IXICO plc
+44 (0) 20 3763 7498
Giulio Cerroni, Chief Executive Officer
Grant Nash, Chief Financial Officer
Cenkos Securities PLC (Nominated adviser and sole broker)
+44 (0) 20 7397 8900
Giles Balleny / Max Gould (Corporate Finance)
Michael F Johnson / Russell Kerr (Sales)
Optimum Strategic Communications
+44 (0) 203 950 9144
Mary Clark / Supriya Mathur/Manel Mateus
ixico@optimumcomms.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHBELFFBFLXBBB
Recent news on IXICO
See all newsREG - IXICO plc - Trading Update
AnnouncementREG - IXICO plc - Share option awards and PDMR Dealing
AnnouncementREG - IXICO plc - FDA Clearance of Alzheimer's Diagnostic Biomarker
AnnouncementREG - IXICO plc - Holding(s) in Company
AnnouncementREG - IXICO plc - Half-year Report
Announcement